Save time and get answers to complex questions with AI chat
Dabrafenib btd date 2023?Stribild expiry date?Drugpatentwatch skyrizi biologic patent analysis?Alogliptin benzoate cost?Sun pharma bortezomib?
See the DrugPatentWatch profile for Carisoprodol
Carisoprodol is a controlled substance. In the United States, it is classified as a Schedule IV drug under the Controlled Substances Act.
Because carisoprodol is Schedule IV, it’s subject to additional prescribing and dispensing rules compared with non-controlled medications. In practice, that means stricter handling around refills, recordkeeping, and prescription verification.
Carisoprodol’s Schedule IV status distinguishes it from many non-controlled muscle relaxants (for example, drugs that are not federally scheduled). Other muscle relaxants that are controlled may have different schedules, depending on their risk profile.
Drug scheduling can change over time if regulators update risk/abuse findings. If you need the most current classification, check the latest DEA/official labeling for the exact product you’re using.
No sources were provided in the prompt to cite.
Other Questions About Carisoprodol :